Interactions of ofloxacin and erythromycin with the multidrug resistance protein (MRP) in MRP-overexpressing human leukemia cells

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 6, 2000, Pages 1697-1700

  Terashi, Kenji ^a,b   Oka, Mikio ^a   Soda, Hiroshi ^a   Fukuda, Minoru ^a   Kawabata, Shigeru ^a   Nakatomi, Katsumi ^a   Shiozawa, Ken ^a   Nakamura, Takashi ^a   Tsukamoto, Kazuhiro ^a   Noguchi, Yuji ^a   Suenaga, Mitsuhiro ^a   Tei, Chuwa ^b   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPOXICILLIN; CALCEIN; CEFOTIAM; CEFTAZIDIME; CIPROFLOXACIN; CLARITHROMYCIN; ENOXACIN; ERYTHROMYCIN; GENTAMICIN; KANAMYCIN; MULTIDRUG RESISTANCE PROTEIN; OFLOXACIN; PIPERACILLIN; TOSUFLOXACIN; VINCRISTINE;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG PROTEIN BINDING; DRUG SENSITIVITY; GENE FUNCTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG INTERACTIONS; ERYTHROMYCIN; FLUORESCEINS; GENES, MDR; HUMANS; LEUKEMIA; OFLOXACIN; P-GLYCOPROTEIN; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 0034093175     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.6.1697-1700.2000     Document Type: Article

References (24)

1. Ambudkar, S. V., S. Dey, C. A. Hrycyna, M. Ramachandra, I. Pastan, and M. M. Gottesman. 1999. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 39:361-398.
2. Feller, N., C. M. Kuiper, J. Lankelma, J. K. Ruhdai, R. J. Scheper, H. M. Pinedo, and H. J. Broxterman. 1995. Functional detection of MDR1/p170 and MRP/p190-mediated multidrug resistance in tumour cells by flow cytometry. Br. J. Cancer 72:543-549.
3. Flens, M. J., G. J. Zaman, P. Valk, M. A. Izquierdo, A. B. Schroeijers, G. L. Scheffer, P. Groep, M. Hass, C. J. Meijer, and R. J. Scheper. 1996. Tissue distribution of the multidrug resistance protein. Am. J. Pathol. 148:1237-1247.
4. Foote, E. F., and C. E. Halstenson. 1998. Effects of probenecid and cimetidine on renal disposition of ofloxacin in rats. Antimicrob. Agents Chemother. 42:456-458.
5. Gollapudi, S., F. Thadepalli, C. H. Kim, and S. Gupta. 1995. Difloxacin reverses multidrug resistance in HL-60/AR cells that overexpress the multidrug resistance-related (MRP) gene. Oncol. Res. 7:213-225.
6. Gottesman, M. M., and I. Pastan. 1993. Biochemistry of multidrug resistance mediated hy the multidrug transporter. Annu. Rev. Biochem. 62:385-427.
7. Hofsli, E., and J. Nissen-Meyer. 1989. Reversal of drug resistance by erythromycin: erythromycin increases the accumulation of actinomycin D and doxorubicin in multidrug-resistanl cells. Int. J. Cancer 44:149-154.
8. Hollo, Z., L. Homolya, C. W. Dabis, and B. Sarkadi. 1994. Calcein accumulation as a fluorometric functional assay of the multidrug transporter. Biochim. Biophys. Acta 1191:384-388.
9. Kim, R. B., M. F. Fromm, C. Wandel, B. Leake, A. J. Wood, D. M. Roden, and G. R. Wilkinson. 1998. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J. Clin. Investig. 101:289-294.
10. Kool, M., M. Dehaas, G. L. Scheffer, R. J. Scheper, M. J. T. van Eijk, J. A. Juijn, F. Baas, and P. Boast. 1997. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 57:3537-3547.
11. Kool, M., M. van der Linden, M. de Haas. F. Baas, and P. Borst. 1999. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res. 59:175-182.
12. Loe, D. W., R. G. Deeley, and S. P. Cole. 1996. Biology of the multidrug resistance-associated protein, MRP. Eur. J. Cancer 32A:945-957.
13. Mosmann. T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63.
14. Murray, M. 1997. Drug-mediated inactivation of cytochrome P450. Clin. Exp. Pharmacol. Physiol. 24:465-470.
15. Narasaki, F., I. Matsuo, N. Ikuno, M. Fukuda, H. Soda, and M. Oka. 1996. Multidrug resistance-associated protein (MRP) gene expression in human lung cancer. Anticancer Res. 16:2079-2082.
16. Okano, T., H. Maegawa, K. Inui, and R. Hori. 1990. Interaction of ofloxacin with organic cation transport system in rat renal brush-border membranes. J. Pharmacol. Exp. Ther. 255:1033-1037.
17. Rao, V. V., J. L. Dahlheimer, M. E. Bardgett, A. Z. Snyder, R. A. Finch, A. C. Sartorelli, and D. Piwnica-Worms. 1999. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. Proc. Natl. Acad. Sci. USA 96:3900-3905.
18. Rodrigues, A. D., E. M. Roberts, D. J. Mulford, Y. Yao, and D. Quellet. 1997. Oxidative metabolism of clarithromycin in the presence of human liver microsomes: major role for the cytochrome P4503A (CYP3A) subfamily. Drug Metab. Dispos. 25:623-630.
19. Rowinsky, E. K., and R. C. Donehower. 1991. The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics. Pharmacol. Ther. 52:35-84.
20. Schuetz, E. G., K. Yasuda, K. Arimori, and J. D. Schuetz. 1998. Human MDR1 and mouse mdr1a P-glycoprotein alter the cellular retention and disposition of erythromycin, but not of retinoic acid or benzo(a)pyrene. Arch. Biochem. Biophys. 350:340-347.
21. Takano, M., R. Hasegawa, T. Fukuda, R. Yumoto, J. Nagai, and T. Murakami. 1998. Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cells. Eur. J. Pharmacol. 358:289-294.
22. Vazifeh, D., H. Abdelghaffar, and M. T. Labro. 1997. Cellular accumulation of the new ketolide RU 64004 by human neutrophils: comparison with that of azithromycin and roxithromycin. Antimicrob. Agents Chemother. 41:2099-2107.
23. Wakasugi, H., I. Yano, T. Ito, T. Hashida, T. Futami, R. Nohara, S. Sasayama, and K. Inui. 1998. Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein. Clin. Pharmacol. Ther. 64:123-128.
24. Wilkinson, G. R. 1996. Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans. J. Pharmacokinet. Biopharm. 24:475-490.